Boardroom Alpha
Start trial
8-K primary document
NRC · Current Report (Form 8-K) · Filed April 20, 2026

Nrc Health — 8-K exhibit

ex_943656.htm
Nrc Health on Boardroom Alpha
ex_943656.htm

Exhibit 3.1

 

STATE OF DELAWARE

CERTIFICATE OF AMENDMENT

OF

CERTIFICATE OF INCORPORATION

OF

NATIONAL RESEARCH CORPORATION

 

 

National Research Corporation (the "Corporation"), a corporation organized and existing under the General Corporation Law of the State of Delaware, hereby certifies as follows:

 

1.    This Certificate of Amendment (this "Certificate of Amendment") amends the following provision of the Corporation's Certificate of Incorporation filed with the Secretary of State on June 30, 2021 (the "Certificate of Incorporation").

 

2.    The Corporation’s total assets, as defined in Section 503(i) of the General Corporation Law of the State of Delaware, are not less than $10,000,000.

 

3.    The Corporation requests that the Division of Corporations in the Department of State waives the requirement under Section 102(a)(1)(i) of the General Corporation Law of the State of Delaware that the name of the Corporation must contain certain identifying words (or abbreviations thereof, with or without punctuation).

 

4.    Article I of the Certificate of Incorporation is hereby amended and restated in its entirety as follows:

 

The name of the corporation is NRC Health (the “Corporation”).

 

5.    This Certificate of Amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

 

6.    All other provisions of the Certificate of Incorporation shall remain in full force and effect.

 

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed this 15th day of April, 2026.

 

 

Authorized Officer

 

By: /s/ Shane Harrison         
Name: Shane Harrison
Its: Chief Financial Officer

 

 
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer